Concepedia

Zhengming Yan

ZY

14

Publications

647

Citations

13

H-Index

2008

Active since

Affiliations

Pfizer (United States)(Current)

Southern Medical University

Zhujiang Hospital

Zhengming Yan is an author at Pfizer (United States) specializing in tumor biology, oncology, and medicine.

Top concepts

Publications per year

2008–2022

14

Publications

14

Synergistic Effect of the γ-Secretase Inhibitor PF-03084014 and Docetaxel in Breast Cancer Models

Cathy C. Zhang, Zhengming Yan, Qing Zong et al. · Stem Cells Translational Medicine · 2013 · 91 citations · Full text

, , +18

[18F]FLT–PET Imaging Does Not Always “Light Up” Proliferating Tumor Cells

Cathy C. Zhang, Zhengming Yan, Wenlin Li et al. · Clinical Cancer Research · 2011 · 76 citations

PF-03732010: A Fully Human Monoclonal Antibody against P-Cadherin with Antitumor and Antimetastatic Activity

Cathy C. Zhang, Zhengming Yan, Qin Zhang et al. · Clinical Cancer Research · 2010 · 74 citations

Biomarker and Pharmacologic Evaluation of the γ-Secretase Inhibitor PF-03084014 in Breast Cancer Models

Cathy C. Zhang, Adam Pavlı́c̀ek, Qin Zhang et al. · Clinical Cancer Research · 2012 · 65 citations

PF-00477736 Mediates Checkpoint Kinase 1 Signaling Pathway and Potentiates Docetaxel-Induced Efficacy in Xenografts

Cathy Zhang, Zhengming Yan, Cory L. Painter et al. · Clinical Cancer Research · 2009 · 57 citations

Rows per page

1–5 of 14